Market Overview

Boston Scientific Buys Rhythmia Medical; Sees Immaterial in FY13 and FY14

Share:
Related BSX
6 Reasons Why Needham Upgraded Boston Scientific
Benzinga's Top Upgrades, Downgrades For December 8, 2017
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering (Seeking Alpha)

Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.  Rhythmia Medical is based in Burlington, MA.  The transaction is expected to close by Friday, October 12^th.

Posted-In: News M&A

 

Related Articles (BSX)

View Comments and Join the Discussion!